Population genomics of pneumococcal carriage in South Africa following the introduction of the 13-valent pneumococcal conjugate vaccine (PCV13) immunization

被引:7
|
作者
Javaid, Nida [1 ,2 ]
Olwagen, Courtney [3 ,4 ]
Nzenze, Susan [3 ,4 ]
Hawkins, Paulina [5 ]
Gladstone, Rebecca [2 ]
McGee, Lesley [5 ]
Breiman, Robert F. [6 ]
Bentley, Stephen D. [2 ,7 ]
Madhi, Shabir A. [3 ,4 ]
Lo, Stephanie [2 ]
机构
[1] Lahore Univ Management Sci, Syed Babar Ali Sch Sci & Engn, Dept Biol, Lahore, Pakistan
[2] Wellcome Sanger Inst, Parasites & Microbes, Hinxton, England
[3] Univ Witwatersrand, Natl Res Fdn Vaccine Preventable Dis, Dept Sci & Technol, Johannesburg, South Africa
[4] Univ Witwatersrand, Fac Hlth Sci, Sch Pathol, Med Res Council Resp & Meningeal Pathogens Res Un, Johannesburg, South Africa
[5] Ctr Dis Control & Prevent, Atlanta, GA USA
[6] Emory Global Hlth Inst, Atlanta, GA USA
[7] Univ Cambridge, Dept Pathol, Cambridge, England
来源
MICROBIAL GENOMICS | 2022年 / 8卷 / 06期
关键词
antimicrobial resistance; pneumococci; pneumococcal carriage; pneumococcal conjugate vaccine; pneumococcal genomics; TEMPORAL-CHANGES; COLONIZATION; DISEASE;
D O I
10.1099/mgen.0.000831
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
Streptococcus pneumoniae is a major human pathogen responsible for over 317000 deaths in children <5 years of age with the burden of the disease being highest in low-and middle-income countries including South Africa. Following the introduction of the 7-valent and 13-valent pneumococcal conjugate vaccine (PCV) in South Africa in 2009 and 2011, respectively, a decrease in both invasive pneumococcal infections and asymptomatic carriage of vaccine -type pneumococci were reported. In this study, we described the changing epidemiology of the pneumococcal carriage population in South Africa, by sequencing the genomes of 1825 isolates collected between 2009 and 2013. Using these genomic data, we reported the changes in serotypes, Global Pneumococ-cal Sequence Clusters (GPSCs), and antibiotic resistance before and after the introduction of PCV13. The pneumococcal carriage population in South Africa has a high level of diversity, comprising of 126 GPSCs and 49 serotypes. Of the ten most prevalent GPSCs detected, six were predominantly found in Africa (GPSC22, GPSC21, GPSC17, GPSC33, GPSC34 and GPSC52). We found a significant decrease in PCV7 serotypes (19F, 6B, 23F and 14) and an increase in non-vaccine serotypes (NVT) (16F, 34, 35B and 11A) among children <2 years of age. The increase in NVTs was driven by pneumococcal lineages GPSC33, GPSC34, GPSC5 and GPSC22. Overall, a decrease in antibiotic resistance for 11 antimicrobials was detected in the PCV13 era. Further, we reported a higher resistance prevalence among vaccine types (VTs), as compared to NVTs; however, an increase in penicillin resistance among NVT was observed between the PCV7 and PCV13 eras. The carriage isolates from South Africa predominantly belonged to pneumococcal lineages, which are endemic to Africa. While the introduction of PCV resulted in an overall reduction of resistance in pneumococcal carriage isolates, an increase in penicillin resistance among NVTs was detected in children aged between 3 and 5 years, driven by the expan-sion of penicillin-resistant clones associated with NVTs in the PCV13 era.
引用
收藏
页数:9
相关论文
共 50 条
  • [41] Prevnar 13, the New 13-Valent Pneumococcal Conjugate Vaccine
    Sucher, Allana J.
    Chahine, Elias B.
    Nelson, Michael
    Sucher, Brandon J.
    ANNALS OF PHARMACOTHERAPY, 2011, 45 (12) : 1516 - 1524
  • [42] Decline in Pneumococcal Nasopharyngeal Carriage of Vaccine Serotypes After the Introduction of the 13-Valent Pneumococcal Conjugate Vaccine in Children in Atlanta, Georgia
    Desai, Ankita P.
    Sharma, Dolly
    Crispell, Emily K.
    Baughman, Wendy
    Thomas, Stepy
    Tunali, Amy
    Sherwood, Logan
    Zmitrovich, April
    Jerris, Robert
    Satola, Sarah W.
    Beall, Bernard
    Moore, Matthew R.
    Jain, Shabnam
    Farley, Monica M.
    PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2015, 34 (11) : 1168 - 1174
  • [43] Recent Advances in Pneumococcal Conjugate Vaccines: A 13-Valent Pneumococcal Conjugate Vaccine
    Ceyhan, Mehmet
    JOURNAL OF PEDIATRIC INFECTION, 2011, 5 (02): : 68 - 73
  • [44] Radiographically confirmed pneumonia in Malawian children and associated pneumococcal carriage after introduction of the 13-valent pneumococcal conjugate vaccine
    Mzumara, Grace
    Chirombo, James
    Swarthout, Todd D.
    Bar-Zeev, Naor
    Harawa, Philliness Prisca
    Jalloh, Mohamed Sanusi
    Kirolos, Amir
    Mukhula, Victoria
    Newberry, Laura
    Ogunlade, Olawale
    Wachepa, Richard
    French, Neil
    Heyderman, Robert S.
    Tam, Pui-Ying Iroh
    PNEUMONIA, 2024, 16 (01):
  • [45] Pneumococcal carriage in children in Ulaanbaatar, Mongolia before and one year after the introduction of the 13-valent pneumococcal conjugate vaccine
    von Mollendorf, Claire
    Dunne, Eileen M.
    La Vincente, Sophie
    Ulziibayar, Mukhchuluun
    Suuri, Bujinlkham
    Luvsantseren, Dashtseren
    Narangerel, Dorj
    Ortika, Belinda D.
    Pell, Casey L.
    Nation, Monica L.
    Alamrousi, Ahmed
    Hinds, Jason
    Demberelsuren, Sodbayar
    Nguyen, Cattram
    Mungun, Tuya
    Mulholland, E. Kim
    Satzke, Catherine
    VACCINE, 2019, 37 (30) : 4068 - 4075
  • [46] A COMPARISON OF THE COST-EFFECTIVENESS OF THE 13-VALENT (PCV13) AND 10-VALENT PNEUMOCOCCAL CONJUGATE VACCINES IN THE UK
    Patel, R.
    Stoykova, B.
    Lloyd, A. C.
    Willingham, J.
    Hollingsworth, R.
    VALUE IN HEALTH, 2009, 12 (07) : A428 - A428
  • [47] Pneumococcal carriage in children and their household contacts six years after introduction of the 13-valent pneumococcal conjugate vaccine in England
    Southern, Jo
    Andrews, Nick
    Sandu, Pamela
    Sheppard, Carmen L.
    Weight, Pauline A.
    Fry, Norman K.
    Van Hoek, Albert Jan
    Miller, Elizabeth
    PLOS ONE, 2018, 13 (05):
  • [48] Real-life effectiveness data on prevention OF COPD and asthma exacerbations with 13-valent pneumococcal conjugate vaccine (PCV13)
    Mezquita, Miguel Angel Hernandez
    Boscam, Alexis Morales
    Sierra, Vanesa Hidalgo
    Ballesteros, Mercedes Sobrino
    Ferrero, Miguel Barrueco
    EUROPEAN RESPIRATORY JOURNAL, 2016, 48
  • [49] PUBLIC HEALTH AND ECONOMIC IMPACT OF 13-VALENT PNEUMOCOCCAL CONJUGATE VACCINE (PCV13) IN AN INFLUENZA PANDEMIC IN SINGAPORE AND HONG KONG
    Rubin, J.
    McGarry, L.
    Klugman, K.
    Strutton, D.
    Gilmore, K.
    Hwang, S.
    Rinaldi, F.
    Weinstein, M.
    VALUE IN HEALTH, 2010, 13 (03) : A9 - A9
  • [50] Effect of the 13-Valent Pneumococcal Conjugate Vaccine on Pneumococcal Meningitis in Children
    Levy, Corinne
    Varon, Emmanuelle
    Bechet, Stephane
    Cohen, Robert
    CLINICAL INFECTIOUS DISEASES, 2016, 62 (01) : 131 - +